The FDA and European approvals for Bromfenac Sodium are for use one day before and two weeks following cataract surgery for the treatment of ocular inflammation and pain. It is a nonsteroidal anti-inflammatory drug.. Reference standards of Bromfenac Sodium API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below
stdClass Object ( [pname] => 7,7'-Bis(4-bromobenzoyl)-1H,1'H-[3,3']-biindolinylidene-2,2'-dione [catalogue_number] => PA 02 47520 [category_ids] => ,80,100,70, [chemical_name] => [weight] => 628.28 [form] => C30H16Br2N2O4 [cas] => 1798431-98-7 [pslug] => 1798431-98-7-7-7-bis-4-bromobenzoyl-1h-1h-3-3-biindolinylidene-2-2-dione-pa0247520 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 02 47520
CAS :
Molecular Formula : C30H16Br2N2O4
Molecular Weight : 628.28
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....